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Overcoming the problems associated with the expression, purification and in vitro handling of membrane proteins requires an understanding of
the factors governing the folding and stability of such proteins in detergent solutions. As a sequel to our earlier report (Biochim. Biophys. Acta 1747
(2005), 133–140), we describe an improved purification procedure and a detailed structural analysis of a fragment of the μ-opioid receptor (‘TM2–3’)
that comprises the second and third transmembrane segments and the extracellular loop that connects them. Circular dichroism (CD) spectroscopy of
TM2–3 in 2,2,2-trifluoroethanol gave a helical content similar to that predicted by published homology models, while spectra acquired in several
detergents showed significantly lower helical contents. This indicates that this part of the μ-opioid receptor has an intrinsic propensity to be highly
helical in membrane-like environments, but that in detergent solutions, this helical structure is not fully formed. Proteolysis of TM2–3 with trypsin
showed that the helical portions of TM2 and TM3 are both shorter than their predicted lengths, indicating that helix–helix interactions in the full-
length receptor are apparently important for stabilizing their conformation. Lengthening the alkyl chain of the detergent led to a small but significant
increase in the helicity of TM2–3, suggesting that hydrophobic mismatch could play an important role in the stabilization of transmembrane helices
by detergents. Protonation of aspartic acid residues in detergent-solubilized TM2–3 also caused a significant increase in helicity. Our results thus
suggest that detergent alkyl chain-length and pH may influence membrane protein stability by modulating the stability of individual transmembrane
segments.
© 2007 Elsevier B.V. All rights reserved.Keywords: G protein-coupled receptor; Opioid receptor; Transmembrane helices; Conformational determinant; Detergent; Circular dichroism1. Introduction
Opioid receptors are responsible for mediating the effects of
opiate drugs and opioid peptides [1,2]. They are members of the
superfamily of Gprotein-coupled receptors, which are character-
ized by the presence of seven putative α-helical transmembrane
segments connected by short intracellular and extracellular loops
[3]. There are three subtypes of opioid receptors, μ, δ, and κ,
each with a unique pharmacological profile and physiological
role(s) [1,2]. Activation of these receptors by opiate drugs has
both beneficial effects such as analgesia, and negative side
effects such as addiction, respiratory depression and constipa-
tion. It is believed that opiates with greater opioid receptor
subtype specificity might exclusively have the beneficial⁎ Corresponding author. Tel.: +1 905 525 9140 x22783; fax: +1 905 522 9033.
E-mail address: ananth@mcmaster.ca (V.S. Ananthanarayanan).
0005-2736/$ – see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2007.01.017analgesic effects without the side effects. The rational design
of such compounds depends on a detailed knowledge of the
structure–function relationships of both opiate compounds and
opioid receptors.
The structure–function relationships of the opioid receptors
have been studied by various techniques. Site-directed mutagen-
esis and the construction of receptor chimeras (reviewed in ref. 4)
have identified specific residues, as well as regions of the
receptors, which are responsible for ligand biding affinity,
ligand–receptor specificity, and receptor activation. Homology
modeling of the opioid receptors has also shed light on the
possible mechanisms of receptor–ligand recognition [5–8]. A
complete understanding of how ligands interact with opioid
receptors would require a detailed three-dimensional picture of
the opioid receptor–ligand complex. Such a feat has not yet been
accomplished experimentally. Opioid receptors, like other integ-
ral membrane proteins, are not as easily amenable to biophysical
1200 A. Kerman, V.S. Ananthanarayanan / Biochimica et Biophysica Acta 1768 (2007) 1199–1210techniques such as X-ray crystallography or high-resolution
NMR spectroscopy as are water-soluble proteins. Because of
their hydrophobic nature and their low natural abundance, such
proteins are difficult to produce and purify in the large
(milligram) quantities required for structural studies [9]. Also,
because such proteins are usually extracted from their native
membrane during purification and subsequent experiments,
maintaining such proteins in a soluble and stable state is
challenging. In the case of GPCRs in particular, most biophysical
studies have focused on the photoreceptor rhodopsin, as the high
natural abundance of this protein has allowed its isolation in large
quantities [10,11]. Extensive biophysical studies have been
limited to a handful of heterologously expressed GPCRs,
including the β2-adrenergic receptor [12,13], an olfactory
receptor [14] a leukotriene receptor [15,16], and receptors for
vasopressin [17], 5-HT4 [18], and chemokines [19]. In the case of
opioid receptors, purification of small amounts of the δ-receptor
from mammalian cell culture has allowed plasmon-waveguide
resonance studies to be carried out [20,21]. However, this low-
resolution technique is somewhat unique in that it requires only
very small amounts of purified protein. High-level expression of
the μ-opioid receptor in Pichia pastoris was recently reported
[22]. However, the protein obtained was in an aggregated and
non-functional form, so that no biophysical studies have yet been
carried out.
An important area of research, therefore, is to work toward
overcoming the difficulties associated with biophysical studies
on GPCRs in particular, and integral membrane proteins in
general. A deep understanding of the root causes of these
difficulties, as well as potential solutions, is intimately
connected to an understanding of the principles governing the
folding and stability of membrane proteins and their interactions
with solubilizing detergents. Such an understanding, in addition
to facilitating the in vitro study of membrane proteins, would
also shed light on the relationship between protein sequence and
structure, thereby facilitating the prediction of membrane
protein structures from the enormous number of sequences
now available to us as a result of genome sequencing efforts.
One approach to the study of integral membrane protein
folding and structure which circumvents the difficulties
discussed above is to produce and characterize protein
fragments comprising loops, transmembrane segments, and
combinations thereof. Such a strategy has been applied
successfully to several helical membrane proteins, including
bacteriorhodopsin [23], rhodopsin [24], the A2 adenosine
receptor [25], and the yeast alpha-factor receptor [26 27]. In
the case of the opioid receptors, the structures of small peptides
containing extracellular loop regions of the δ and κ receptors
have been solved by NMR spectroscopy [28,29]. Conforma-
tional studies of such fragments provide information on their
intrinsic tendency to adopt particular secondary structures.
Studies of the non-covalent interactions between fragments
provide information on the forces responsible for tertiary
structure formation, as well as the effect of tertiary structure on
the formation/stability of secondary structure. The fact that
functional membrane proteins can be reconstituted in vitro from
interacting fragments [30] supports the idea that the study of thestructures and interactions of such fragments are directly
relevant to the folding process of the intact protein.
We recently reported the production, by bacterial expression,
of a double-membrane spanning fragment of the μ-opioid
receptor, which allowed the first biophysical characterization of
opioid receptor transmembrane segments [31].We chose to study
the fragment “TM2–3”, which comprises the second and third
transmembrane domains as well as the extracellular loop that
connects them, because this part of the receptor is known to
contain several residues and motifs that are of critical importance
to ligand binding and receptor activation [31]. Here we report an
improved purification procedure for the fragment, as well as a
detailed analysis of its secondary structure as a function of
membrane-mimetic environment and pH. The implications of our
findings for the folding/stability of opioid receptors, as well as for
studies on detergent-solubilizedGPCRs in general, are discussed.2. Materials and methods
2.1. Materials
1-myristoyl-2-hydroxy-sn-glycero-3-phosphocholine (myristoyl-LPC) and
1-stearoyl-2-hydroxy-sn-glycero-3-phosphocholine (stearoyl-LPC) were
obtained from Avanti Polar Lipids (Alabaster, Alabama). 1-lauryol-2-hydroxy-
sn-glycero-3-phosphoscholine (lauroyl-LPC) and N-lauroylsarcosine were
from Sigma (Oakville, Ontario). Lauryl-dimethylamine-N-oxide (LDAO) was
from Fluka (through Sigma-Aldrich, Oakville, Ontario). Sodium Dodecyl
Sulfate (SDS) was from BioShop (Burlington, Ontario). Perfluorooctanoic acid
(PFO) was from Aldrich (Oakville, Ontario). 2,2,2-trifluoroethanol (TFE) was
from Sigma, and was twice distilled before use. Ni-NTA resin was from
Novagen (Madison, WI). All other materials were of reagent grade or better.
2.2. Construction of the vectors pET-32aΔ and pET-32aΔ-TM2–3
The plasmid pET-32(a)+ was obtained from Novagen. To construct pET-
32aΔ, two PCR primers were obtained: the first was complementary to the XbaI
site in pET-32(a)+, while the second was complementary to the thrombin
cleavage site. The second primer, however, contained mismatches that would
introduce three silent mutations into the sequence encoding the ‘Gly-Ser’ part of
the thrombin cleavage site, and would also convert this sequence into a BamHI
cleavage site. The resulting PCR product was digested with XbaI and BamHI
and ligated into pET-32(a)+ which had been similarly digested. This work was
done in collaboration with Ms. Helen Atkinson.
For the construction of pET-32aΔ-TM2–3, an insert coding for TM2–3
flanked by restriction sites for BamHI and XhoI was prepared by PCR using
pGEX-2T-TM2–3 [31] as template. The resulting insert was digested with
BamHI and XhoI and ligated into pET-32aΔ that had been similarly digested.
2.3. Expression and purification of 6xHis-Trx-TM2–3
The vector pET32aΔ-TM2–3 was transformed into BL21(DE3) using a
calcium chloride/heat shock method [32]. Growth of bacterial cultures,
induction of protein expression and harvesting of cells post-induction, and
lysis of cells were carried out using procedures identical to those described for
GST-TM2–3 [31].
Inclusion bodies containing 6xHis-Trx-TM2–3 were resuspended in
solubilization buffer containing 20 mM Tris–HCl pH 8.0, 100 mM NaCl,
0.5% N-lauroylsarcosine, 100 mM 2-mercaptoethanol using a hand-held
homogenizer. The suspension was incubated at room temperature for 2–3 h
with gentle agitation. Insoluble material was removed by centrifugation at
12,000×g for 20 min. The supernatant was then mixed with∼15 mL of Ni-NTA
resin (Novagen) which had been equilibrated in column wash buffer (20 mM
Tris–HCl pH 8.0; 100mMNaCl; 0.25%N-lauroylsarcosine; 10mM2-ME). The
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The resin was then washed with 5 column volumes of column wash buffer
containing 5 mM imidazole. Bound fusion protein was then eluted using the
same buffer containing 400 mM imidazole. Fractions containing fusion protein
were identified using SDS-PAGE, pooled together, and dialyzed against two
changes (2 l each) of column wash buffer in order to remove imidazole. After
dialysis, thrombin protease (500 units) was added to the fusion protein-
containing solution, and cleavage was allowed to proceed at room temperature
overnight.
To remove thioredoxin, as well as any uncleaved fusion protein, the solution
was incubated with 15 mL of Ni-NTA resin (which had been equilibrated as
described above) for 2–3 h. The flow-through was collected, bound protein was
removed from the resin using imidazole-containing column wash buffer, and the
process was repeated 2–3 times, until nearly all thioredoxin and uncleaved fusion
protein had been removed, as judged by SDS-PAGE. The nearly pure TM2–3
was then prepared for reversed-phase HPLC purification as described previously
[31]. The conditions used for HPLC (solvents, gradient, column, etc.) were also
identical to those described previously [31]. The identity of the final product was
confirmed by ESI mass spectrometry, carried out by Dr. Kirk Green at the
McMaster Regional Centre for Mass Spectrometry.
2.4. Sample preparation
Two different methods were used to prepare detergent-solubilized TM2–3. In
the first method, aliquots of detergent stock solution inmethanolweremixedwith
aliquots of a∼0.7 mg/mL stock solution of TM2–3 in TFE (usually 100–200 μl)
in a test tube (or round-bottom flask, depending on volume) and the solvent was
evaporated under a stream of nitrogen, leaving a detergent/protein film at the
bottom of the tube/flask. The last traces of solvent were removed under vacuum
for at least 1 h. The dry film was dissolved in an appropriate amount of buffer
(10 mM Tris–HCl pH 7.0, 50 mM NaCl) to give the desired concentrations of
protein and detergent. In the second method, an aliquot of the TFE stock solution
of TM2–3 was dried down in a test tube, and dried further under vacuum for 1 h.
The resulting film (containing only protein) was dissolved in buffer containing
the desired amount of detergent. There were no detectable differences in the
experimental results obtained with samples prepared using the two different
methods. Therefore, all results described in this paper are from samples prepared
by the second method. Solutions were centrifuged at 16,000×g in a benchtop
centrifuge before being used for spectroscopy. Samples of TM2–3 in 20 mM
SDS at low pH were prepared by adding aliquots of dilute HCl to a sample
prepared at pH 7.0. The pH after titration was measured using a pH electrode.
Samples of TM2–3 in myristoyl-LPC at low pH were prepared by dissolving
dried-down TM2–3 in low pH buffer (10 mM sodium citrate pH 4.0, 50 mM
NaCl), rather than the usual pH 7.0 buffer.
2.5. CD spectroscopy of TM2–3
All CD spectra were acquired at room temperature on a Jasco J-600
spectropolarimeter using 0.1 or 0.2 cm-path length cylindrical quartz cuvettes.
For samples of TM2–3 in detergents, spectra were acquired from 197 nm to
250 nm in 0.2 nm steps, with a scanning speed of 50 nm/min and a time constant
of 1 s. For samples of TM2–3 in TFE, spectra were acquired from 190 nm to
250 nm using the same parameters. Final spectra were the average of 8 scans.
Background spectra of samples containing detergent but no protein (or in the
case of TFE, TFE with no protein) were acquired in an identical manner and
subtracted from the spectra of protein-containing samples. The concentration of
TM2–3 in samples used for CD spectroscopy was 6–9 μM, and the
concentrations of detergents were 5 mM or 20 mM myristoyl-LPC, 5 mM
lauroyl-LPC, 5 mM stearoyl-LPC, 20 mM SDS, and 20 mM LDAO. For the
LPC detergents, results are presented for 5 mM, although the results for higher
concentrations were comparable.
2.6. Analysis of CD spectra
Protein concentrations were determined by UV absorbance spectroscopy
using an extinction coefficient of ε280=14,440 M
−1 cm−1 calculated using the
formula of Pace et al. [33]. Before calculating the concentration, the A280 of anidentical solution containing detergent and buffer but no protein was subtracted
from the A280 of the protein-containing solution. The calculated concentration
was then used to convert the raw CD data to units of mean-residue molar
ellipticity ([θ], in units of deg-cm2 dmol−1) using the following equation:
½h ¼ ð0:1 hobs MrÞ=ðc d  NÞ
where θobs is the experimentally observed ellipticity,Mr is the molecular weight,
c is the concentration in mg/mL, d is the path-length of the cuvette in cm, and N
is the number of peptide bonds in the polypeptide.
The resulting spectra were analyzed for the proportions of various secondary
structures using the computer programs Contin/LL [34], CDSSTR [35] and
SELCON3 [36], which were obtained as part of the software package CDPro
[37]. The analysis was performed using reference set #4 (containing 43 water-
soluble proteins) of these authors. These programs give results for both
‘distorted’ and ‘regular α-helix’. In this paper, these results were added together
to obtain the total proportions of helix.
2.7. Trypsin digestion of TM2–3
Samples of TM2–3 (7–10 μM) in 5 mM myristoyl-LPC were treated with
trypsin (1:50 enzyme:substrate by weight) at room temperature. At various time
points, the reaction was stopped either by adding PMSF from a 200 mM stock
solution in isopropanol to a final concentration of 2 mM and incubating for at
least 5 min, or by adding one-half volume of three times concentrated SDS
sample buffer and storing at −20 °C. Samples were analyzed by 16.5% SDS-
PAGE using the Tris–Tricine buffer system [38].
For analysis of trypsin digestion results by mass spectrometry, aliquots
(100 μl) of digest reactions were mixed with 4 volumes of ice-cold acetone and
stored at −20 °C for 24–48 h. Precipitated protein was collected by centrifugation
at 16,000×g in a benchtop centrifuge at 4 °C for 10 min. The pellets were allowed
to air-dry and were analyzed by MALDI-TOF mass spectrometry by Dr. Kirk
Green at the McMaster Regional Centre for Mass Spectrometry.
2.8. CD spectroscopy of trypsin-cleaved TM2–3
Samples of TM2–3 that had been cleaved by trypsin for at least 2 h were
analyzed by CD spectroscopy using the same conditions described above
(neither PMSF nor SDS sample buffer were added to these samples). The
concentrations of these samples were verified by absorbance spectroscopy
immediately before CD spectra were acquired. It was verified that, at the
concentrations used, trypsin makes no detectable contribution to either the
absorbance or CD spectra. The CD spectra obtained were converted to units of
mean-residue-molar ellipticity and analyzed for secondary structure content
using the program Contin/LL.
2.9. PFO-PAGE
Samples for PFO-PAGE were prepared by adding one-half volume of
doubly concentrated PFO-PAGE sample buffer [39] to samples of TM2–3
prepared in myristoyl-LPC as described above. Alternatively, aliquots of the
TM2–3 stock solution in TFE were dried down in a test tube, and the dried
protein was dissolved directly in PFO-PAGE sample buffer, either with or
without heating at 37 °C. PFO-PAGE was carried out as previously described
[39], except for the following modifications: 16.5% acrylamide gels were
prepared without detergent; electrophoresis was carried out using the Tris–
Tricine system; PFO was added only to the cathode buffer at a concentration of
0.25%. Electrophoresis carried out at 4 °C or room temperature gave identical
results for the migration behaviour of TM2–3.3. Results
3.1. Expression and purification of 6xHis-Trx-TM2–3
Previously, we reported an expression and purification
procedure for TM2–3 (sequence shown at the bottom of Fig. 2)
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Although TM2–3 could be successfully purified using that
method, aspects of the method that required improvement were
identified. One problem is that because the GST fusion protein is
not purified before thrombin cleavage, several runs of HPLC are
required for purification. This, in turn, necessitates exposing
TM2–3 to strongly acidic organic solvents (i.e. formic acid)
several times. It also requires very large amounts of solvents to
be used. In order to ameliorate such problems, we pursued an
alternative method of TM2–3 expression and purification that
would allow the purification of the fusion protein prior to
cleavage with thrombin. To this end, hexahistidine-tagged
thioredoxin was chosen as an alternative to GST for the fusion
partner. Deber and colleagues had previously used this system to
express and purify fragments of the cystic fibrosis transmem-
brane conductance regulator (CFTR) protein, as well as other
double-membrane-spanning polypeptides [41,42]. As an affinity
tag, polyhistidine is preferable in cases where inclusion bodies
are the starting material for purification, since such a tag allows
efficient affinity purification under denaturing conditions.
Furthermore, if the tag is separated from the target protein by
proteolytic cleavage, then the fusion partner (containing the tag)
can then be removed from the target protein by another round of
affinity chromatography. Both of these features could be used to
significantly improve the purity of TM2–3 before final HPLC
purification. The pET-32(a)+ vector from Novagen allows
expression of target polypeptides as C-terminal fusions to
hexahistidine-tagged thioredoxin. However, because of theFig. 1. Expression, cleavage and purification of 6xHis-Trx-TM2–3. (A) Expression an
E. coli lysate after induction with 1 mM IPTG for 3 h at 37 °C. Lane 3: soluble fract
with 0.5% sarkosyl/100 mM β-mercaptoethanol. Lane 6: protein not solubilized by 0
cleavage of 6xHis-Trx-TM2–3. Lane 1: solubilized fusion protein before Ni-NTA pur
cleaved with thrombin protease at room temperature for ∼20 h. (C) TM2–3 remaini
from reversed-phase HPLC containing purified TM2–3.location of the thrombin cleavage site, thrombin cleavage of a
fusion protein encoded by this vector leaves many (>30) vector-
encoded residues attached to the N-terminus of the target
protein. The vector was modified in order to move the thrombin
cleavage site to a position overlapping the BamHI restriction site
in the multiple cloning region. As a result, fusion proteins
expressed from this vector can be cleaved with thrombin, and
only two vector-derived residues (Gly–Ser) are added to the N-
terminus of the target protein. Such a vector should be of general
utility for proteins for which expression as a 6xHis-thioredoxin
fusion is desirable, but additional vector-derived residues are not
acceptable.
Induction of E. coli cells harbouring the pET32Δ-TM2–3
plasmid led to high levels of expression of the 6xHis-Trx-TM2–3
fusion protein, as evidenced by the appearance of an intense band
at ∼23 kDa on SDS-PAGE gels (Fig. 1A). Inclusion bodies
containing 6xHis-Trx-TM2–3 were processed in a manner
similar to the processing of GST-TM2–3 inclusion bodies [31],
except that a nickel affinity purification step was carried out prior
to thrombin cleavage. This led to a partial purification of the
fusion protein (Fig. 1B). After efficient cleavage of the fusion
protein in the presence of sarkosyl by thrombin, the 6xHis–Trx
fusion partner, as well as uncleaved fusion protein, was separated
from liberated TM2–3 by 2–3 additional incubations with Ni-
NTA resin. This led to a very high degree of purity, even before
HPLC (Fig. 1C). The final purification of TM2–3was carried out
by reversed-phase HPLC using the exact same conditions that
were used in the GST-TM2–3 method. In this case, however,d solubilization of 6xHis-Trx-TM2–3. Lane 1: Uninduced E. coli lysate. Lane 2:
ion of induced cell lysate. Lane 4: insoluble fraction. Lane 5: protein solubilized
.5% sarkosyl/100 mM β-mercaptoethanol. (B) Partial purification and thrombin
ification. Lane 2: fusion protein after Ni-NTA purification. Lane 3: fusion protein
ng after incubations of cleaved fusion protein with Ni-NTA resin. (D) Fractions
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over the HPLC column (Fig. 1D). The identity of the final
product was confirmed by ESI mass spectrometry.
3.2. Predicted secondary structure of TM2–3
The structure of the μ-opioid receptor has been studied by
several investigators using homology modeling. The most
recent models from the group of Henry Mosberg are based on
the crystal structure of rhodopsin, combined with some
experimentally derived constraints [7,8]. The predicted second-
ary structure of the TM2–3 fragment, based on these homology
models, was determined by rendering the structure of this part
of the receptor in the program ‘RasMol’ using the coordinates of
the model from the website of the Mosberg lab (http://
mosberglab.phar.umich.edu/resources/; Fig. 2, top). In particu-
lar, we used the model of the receptor bound to the antagonist
BNI, as there were no major secondary structural differences
between this model and the agonist-bound model. This
procedure shows that 76% of the residues in TM2–3 are in a
helical conformation. The two helices are relatively long, with
29 residues in TM2 and 33 residues in TM3. Importantly, both
helices are significantly longer than the ∼19–20 residue mini-
mum for spanning a lipid bilayer. The results obtained using the
homology models of Zhorov and Ananthanarayanan [6], which
were developed before the availability of the rhodopsin crystalFig. 2. Structure of TM2–3 from homology modeling. Residues 97–176 of a homo
rendered using the program Rasmol v2.6. Shown are the locations of TM2 and TM3
Squares show the locations of bonds expected to be resistant to trypsin cleavage. Bel
double-underlined and the most hydrophobic stretches in bold. Also shown are all
residues.structure, gave nearly identical results, with the only differences
being the exact residues that began/terminated the two helices.
3.3. CD spectroscopy of TM2–3
The secondary structure of TM2–3 was determined experi-
mentally using CD spectroscopy. The CD spectra of TM2–3 in
various environments are shown in Fig. 3. Initially, the CD
spectrum of TM2–3 was determined in TFE, myristoyl-LPC and
SDS (Fig. 3A). Each of the three spectra showed characteristic
features of the spectrum of an α helix: double minima at
∼208 nm and ∼220 nm and a cross-over point at ∼200 nm.
There are, however, significant differences between the
magnitudes of the two minima between the three spectra,
suggesting significant differences in secondary structural
content. The relative amounts of secondary structure were
estimated using the three programs in the CDPro software
package. The three programs in this package have been shown to
give reliable estimates of the secondary structure of detergent-
solubilized membrane proteins from CD data [43]. The results
for the program Contin/LL (helix only) are shown in Table 1A.
The results for different samples, using protein from the same
preparation, were generally within 1–2% of each other. The
results for samples prepared using protein from different
preparations differed by up to ∼3–4% from one another—
therefore, the effects of changing detergents or pH on TM2–3logy model of the μ-opioid receptor developed by Fowler et al., 2004 [7] were
, as well as the locations of the three aspartic acid residues in this polypeptide.
ow the picture, the sequence of TM2–3 [40] is shown, with the helical stretches
potential trypsin cleavage sites (boxed), based on the presence of Lys and Arg
Fig. 3. CD spectroscopy of TM2–3. (A) TM2–3 dissolved in neat TFE, 5 mM
myristoyl-LPC and 20 mM SDS. (B) TM2–3 in 5 mM myristoyl-LPC, 20 mM
SDS and 20 mM LDAO. The spectra in myristoyl-LPC and SDS from ‘A’ are
reproduced here to facilitate direct comparison with the spectrum in LDAO. (C)
TM2–3 in 5 mM myristoyl-LPC and 5 mM lauroyl-LPC. The spectra in ‘C’
were obtained using protein from a different preparation, accounting for the
slight differences in intensity and signal-to-noise ratio between them and the
spectra in ‘A’ and ‘B’.
Table 1
Helical contents of TM2–3 in various environments
(A) Different solvents/detergents Detergent/Solvent %Helix a
TFE 78±1b
SDS 38±1
LDAO 39.6 c
myristoyl-LPC 44.1±0.4
(B) Effect of alkyl chain length Detergent (Alkyl chain length) d %Helix a
myristoyl-LPC(14) 46.2±0.9
lauroyl-LPC(12) 42.0±0.3
a Mean±standard error for several measurements (generally n=3).
b Mean±standard error for % helix determined for one sample, based on at
least 3 measurements (by quantitative amino acid analysis) of the TM2–3
concentration of the sample.
c Helix content was only accurately determined for one sample, due to
technical difficulties with sample preparation.
d Results in parts ‘A’ and ‘B’ of the Table were obtained using protein from
different preparations.
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same protein preparation. We had previously reported the results
of CD spectroscopy and secondary structure analysis for TM2–3
that had been expressed as a GST fusion protein [31], and the
results reported here are generally consistent with those reported
previously. Because of experimental issues such as the use of
detergent-containing buffers, it was difficult to obtain spectral
data below 197 nm. It has been reported that the programContin/
LL shows the greatest accuracy in the estimation of secondary
structure content in the absence of data below 200 nm [37].
Therefore, the estimates of helical content from Contin/LL will
be used throughout this paper. The two other programs in the
CDPro package (CDSSTR and SELCON3) always gaveestimates of helical content that were within ∼6% of the
Contin/LL estimates. Importantly, each of the three programs
gave similar results vis-à-vis the differences between the helical
contents in different detergents, different pH, etc.
The estimated helical content determined in TFE (78±1%) is
very close to the predicted helical content based on homology
modeling (76%), with the values in the two detergents being
significantly lower, and different from each other (Table 1). The
high value in TFE is not surprising, as TFE is known to be a
solvent that stabilizes α-helical structure in polypeptides that
have an intrinsic ability to form such structures [44].
3.4. Dependence of TM2–3 secondary structure on detergent
type
The difference in the helical content of TM2–3 in SDS and
LPC could potentially be explained in two ways. One expla-
nation is that electrostatic interactions between SDS and the
polypeptide, which might affect helical stability, do not occur in
zwitterionic LPC. Another possibility is that a lower helical
content in SDS is due to the ability of SDS (a strongly dena-
turing detergent) to denature portions of proteins that are
solvent-exposed. In order to investigate this possibility in the
case of TM2–3, CD spectra were obtained with protein dis-
solved in LDAO, a milder, zwitterionic detergent, which has
been used to solubilize and purify other integral membrane
proteins in a properly folded and functional form [15]. Both
LDAO and SDS have the same alkyl chain length (12 carbons),
which would specifically allow the effects of changing the head
group charge and structure to be studied. Surprisingly, the CD
spectrum of TM2–3 in LDAO was nearly identical to the
spectrum in SDS (Fig. 3B), suggesting that neither the negative
charge nor the strong denaturing property of SDS is responsible
for the lower amount of α helix in this detergent as opposed to
LPC (Table 1A).
The presence of similar amounts of α helix in SDS and
LDAO (both containing 12-carbon alkyl chains), and the higher
Fig. 4. Cleavage of TM2–3 by Trypsin. Lane 1: 0 h. Lane 2: 2 h. Lane 3: 24 h.
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suggested that alkyl chain length might be an important factor in
modulating the helical content of TM2–3. To test this, CD
spectra were obtained for TM2–3 dissolved in lauroyl-LPC
(containing a 12-carbon alkyl chain) and stearoyl-LPC (contain-
ing an 18-carbon alkyl chain). If alkyl chain-length were the key
factor affecting the secondary structure of TM2–3, then the
secondary structure in lauroyl-LPC, SDS and LDAO would be
expected to be similar, while the helical content in myristoyl-
LPC would be higher, and the helical content in stearoyl-LPC
even higher. The CD spectrum in lauroyl-LPC indeed indicated
that TM2–3 had a significantly lower helical content in this
detergent than in myristoyl-LPC (Fig. 3C, Table 1B), while the
spectrum in stearoyl-LPC was nearly indistinguishable from the
spectrum in myristoyl-LPC (data not shown). A slight dif-
ference between the spectra in stearoyl- and myristoyl-LPC,
corresponding to a small increase in helical content, could
occasionally be observed, although this difference was difficult
to reproduce because of poor sample stability and solubility.
Overall, the results suggest that for the detergents containing 12
or 14-carbon-long alkyl chains, chain length may be a signi-
ficant factor influencing the conformation of TM2–3.
3.5. Oligomerization state of TM2–3
A possible factor that could influence the secondary structure
of TM2–3 is oligomer formation due to helix–helix interac-
tions. Electrophoresis is often used to assess the oligomerization
state of proteins or peptides containing transmembrane seg-
ments. SDS-PAGE can detect oligomerization of peptides that
have a very strong propensity to interact, while PFO-PAGE can
report on weaker oligomeric interactions as well [39]. Many
water-soluble and membrane proteins have been shown to
maintain their oligomeric structure in PFO-PAGE [39].
Both SDS-PAGE and PFO-PAGE were therefore used to
assess the propensity of TM2–3 to form oligomers in detergent
solution. SDS-PAGE was carried out using both boiled and
unboiled samples of TM2–3 in SDS. In both cases, TM2–3 runs
as a single band at approximately the same rate as the 6 kDa
molecular marker (data not shown). This is consistent with
TM2–3 being solely in a monomeric state in SDS. The same
result was obtained in PFO-PAGE (data not shown). The results
did not depend on the particular way in which the samples were
prepared, such as incubation at either room temperature or
37 °C before electrophoresis. A study by Therien and Deber
[45] showed that PFO was significantly more permissive of
helix–helix interactions than SDS, lysophosphatidylcholines
and lysophosphatidylglycerols. The result obtained with TM2–
3 therefore suggests that TM2–3 is likely monomeric in the
lysophosphatidylcholine detergents used in this work, although
other techniques such as analytical ultracentrifugation and/or
resonance energy transfer could be used to further confirm this.
3.6. Native-state proteolysis of TM2–3 in detergent
The relatively low helical content of TM2–3 in detergents
suggests that there are parts of the polypeptide that are predictedto be helical by homology modeling, but which are, in fact, in an
extended/disordered conformation in detergent micelles. To help
identify such parts of the polypeptide, TM2–3 dissolved in
myristoyl-LPCwas subjected to digestion by trypsin protease. In
order for a given peptide bond to be accommodated in the active
site pocket of a protease, the bond, as well as the region imme-
diately surrounding it, must be either disordered and flexible, or
capable of undergoing local unfolding [46,47]. Such require-
ments for cleavage allow proteolysis to be used as a structural
probe, revealing the structure and dynamics of a protein or
peptide in the vicinity of potential proteolytic cleavage sites
[46].
The sequence of TM2–3 contains several potential cleavage
sites for trypsin (Fig. 2, bottom), which cleaves specifically at
the C-terminus of Lys or Arg residues. The structure of TM2–3
predicted by homology modeling suggests that the Lys–Thr
bond near the beginning of TM2, the Lys–Ile bond near the
beginning of TM3 and the Arg–Tyr near the end of TM3 (Fig. 2,
top), which are proximal to (or within) an α helix, should be
significantly resistant to proteolysis by trypsin.
Treatment of TM2–3 in myristoyl-LPC micelles with trypsin
resulted in the disappearance of full-length protein within 2 h
(Fig. 4, lane 2). The cleaved protein ran as a single relatively
sharp band in SDS-PAGE, and seemed to be stable for fairly
long periods (up to 24 h; Fig. 4, lane 3). The trypsin cleavage
products were analyzed in more detail by precipitating the
cleaved protein and subjecting it to MALDI-TOF mass
spectrometry. The identities of the peaks in the mass spectrum
were then determined by comparing their masses to the
calculated masses of possible TM2–3 trypsin cleavage
products. The results indicated that insignificant amounts of
full-length TM2–3 remained after 2 h of cleavage, in agreement
with the observations from SDS-PAGE. Furthermore, no peaks
were observed that suggested cleavage of the Lys–Ile bond near
the beginning of TM3 (Tables 2, 3), indicating that this bond
was completely protected from proteolysis. All other bonds,
including those predicted from homology modeling to be
protease-resistant, were cleaved by trypsin (Table 3). These
results suggest that dynamic, unfolded regions are present near
the N-terminus of TM2 and the C-terminus of TM3, indicating
that in detergent micelles, both of these helices are shorter than
their lengths predicted by homology modeling.
An alternative explanation of the results is that the cleaved
bonds do in fact reside in/near helical structures, but these
structures are dynamic and can undergo transient local
unfolding, increasing their protease susceptibility. To further
investigate this possibility, the CD spectrum of TM2–3 was
Table 2
Identification of cleavage fragments by mass spectrometry
Experimental mass (Da) Theoretical mass Identity of fragment
8567.2 8568.19 Met7–Lys82+4 oxygens
8292.1 8292.8 Ile9–Lys82+3 oxygens
7295.6 7297.56 Ile9–Arg73+3 oxygens
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part of the protein that is not helical (i.e. is flexible and
dynamic) to begin with, then no major change in the CD
spectrum of the cleaved protein should be expected. On the
other hand, if the protein is cleaved in a region that is stable and
helical but undergoes local unfolding, then one might expect a
significant drop in the secondary structure of the protein, since
“refolding” would be prevented after cleavage of such a bond
[46]. Two hours after trypsin cleavage, there were only minimal
changes in the CD spectrum of TM2–3 (data not shown).
Analysis with Contin/LL shows that the change in the spectrum
only corresponds to a∼1% change in helical content. After 24 h
of cleavage, there is no further change in the CD spectrum (data
not shown). Overall, the data suggest that cleavage of the
trypsin-susceptible bonds in TM2–3 has an insignificant effect
on the secondary structure of the protein. Therefore, the
protease-susceptible bonds reside in unstructured regions of the
polypeptide, confirming that in myristoyl-LPC, TM2 and TM3
are both shorter than their lengths predicted by homology
modeling.
3.7. Effect of pH on TM2–3 secondary structure
An additional factor that may contribute to the relatively low
helicity of TM2–3 in detergents is the fact that TM2–3 contains
three aspartic acid residues, two of which are near the centre of
the putative transmembrane segments (Fig. 2). The presence of
charged residues in a transmembrane segment is unfavourable,
and may lead to structural adaptations that allow the charged
residue to reside in a more polar/aqueous environment [48].
This, in turn, could affect the overall structure of the polypeptide.
To determine the impact of charged Asp residues on the
secondary structure of TM2–3, the CD spectrum of detergent-
solubilized TM2–3 was determined at neutral pH and low pH.
CD spectroscopy showed that upon dropping the pH to ∼4 or
lower, a situation in which all of the Asp residues in the
polypeptide would likely be in their protonated states, there is a
significant increase in the helicity of TM2–3 dissolved in SDSTable 3
Potential and experimentally determined Trypsin cleavage sites in TM2–3
Bond Predicted to be
cleaved/protected
Found to be
cleaved/protected
Arg3–Tyr4 cleaved – a
Lys6–Met7 partial protection – a
Lys8–Thr9 protected cleaved
Lys49–Ile50 protected protected
Arg73–Tyr74 protected cleaved
a Could not be determined with certainty from the results.(Fig. 5). Analysis of the spectra at both pH's with Contin/LL
suggests that protonation of the Asp residues of TM2–3 results
in a∼5% increase in the amount of α helix, corresponding to an
extra ∼4 residues adopting α helical structure. Importantly, the
helical content at low pH in detergent micelles is still
significantly lower than the helicity in TFE, or the helicity
predicted by homology modeling. This suggests that, while the
protonation state of the Asp residues has some impact on TM2–3
structure, it is not the sole reason for the significant difference
between the predicted and experimentally found secondary
structures. The fact that a similar change in α helical content
occurs in both SDS and LPC upon a drop in pH (data not shown)
suggests that changes in detergent structure and pH have
independent effects on the conformation of the polypeptide.
4. Discussion
4.1. Secondary structure of TM2–3
In our initial characterization of the TM2–3 fragment [31],
we suggested that the high helicity observed in TFE did not
represent the ‘native’ helicity of the fragment. However, this
argument was based on reports that TFE induces non-native
helical structural in certain proteins—particularly globular
proteins with high beta-sheet content [49,50]. In contrast to
this, in the case of protein fragments that comprise primarily
helical, turn and random-coil structures in the native state, it has
been frequently shown that TFE stabilizes the native secondary
structure of the fragment—that is, it does not “induce” any extra
helical structure that is absent in the native structure [51].
Similarly, TFE maintains random-coil, β-turn, and even β-
hairpin structures [52,53] in peptides that have an intrinsic
propensity to form such structures. In the case of rhodopsin (a
GPCR), peptide fragments of the protein dissolved in organic
solvent faithfully reported on the structure that those sequences
adopt in the native structure [24]. Based on these facts, it is
reasonable to conclude that the secondary structure of TM2–3
in TFE represents the intrinsic secondary-structural propensity
of this part of the μ-opioid receptor. The similarity between theFig. 5. Effect of pH on TM2–3 Secondary structure. The sample contained
∼9 μMTM2–3 in 20 mM SDS. Spectra were acquired as described in Materials
and methods.
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modeling [7,8] and the structure determined in TFE implies that
this is the first direct biophysical evidence in support of the
homology model, with respect to the secondary structure of this
portion of the protein.
In contrast to the secondary structure in TFE, the secondary
structure of the TM2–3 portion of the receptor is not fully
formed in the various detergent micelles as gleaned from the
CD data. There are other examples in which the helical
content of a peptide corresponding to a transmembrane
segment, when determined in membrane-mimetic environ-
ments such as detergent micelles or lipid bilayers, is sig-
nificantly lower than the expected value (based on hydropathy
plots or sequence homology). These include a peptide com-
prising the second transmembrane segment of the A2 adeno-
sine receptor [25], a peptide comprising the sixth transmem-
brane domain of the yeast pheromone receptor [54], and
helices C, F and G of bacteriorhodopsin [55]. The lower-than-
expected helicity implies that, while the secondary structural
preference (i.e. the preference to form a helix) of transmem-
brane segments depends primarily on local sequence informa-
tion, the stability of these regions, in the context of amphi-
philic environments such as micelles or bilayers, depends on
long-range interactions with other parts of the protein. In the
case of α-helical membrane proteins, this means that helix–
helix interactions (possibly in the context of helix–loop–helix
motifs; ref. 56) may sometimes play a key role in stabilizing
the conformation and transmembrane disposition of transmem-
brane α helices. This has been shown to be the case for peptides
corresponding to the transmembrane segment 2 of the A2 ade-
nosine receptor [25], as well as transmembrane segments of
bacteriorhodopsin [55]. In both cases, fragments that had lower-
than-expected helical contents on their own had their helical
contents increase upon interactions with other fragments of the
protein.
The results of trypsin digestion (in combination with CD
spectroscopy of the cleaved polypeptide) indicate that bonds
near the N-terminus of TM2 and C-terminus of TM3 that are
predicted to be within helical regions by homology modeling
are, in fact, within dynamic random coil structures (Table 3).
These bonds are within 1–3 residues from the predicted ends
of the helices (Fig. 2). It has been suggested that susceptibility
to trypsin digestion requires a peptide bond to reside in a
stretch which is dynamic and unfolded and is at least 12
residues long [47]. Therefore, it can be concluded that at
neutral pH in myristoyl-LPC, both TM2 and TM3 are shorter
than their lengths predicted by homology modeling by at least
6–9 residues. In particular, the locations of the trypsin-
susceptible bonds suggest that the N-terminal end of TM2 and
the C-terminal end of TM3 must depend on tertiary interactions
for their stability. The lack of stability of these regions of the
polypeptide may be related to the inability of a detergent
micelle to accommodate the entire lengths of TM2 and TM3,
resulting in the protrusion of the ends of TM2 and TM3 into
the aqueous solvent where helical structures are much less
stable. Further studies using different classes of detergents, as
well as lipid bilayers, would be needed to determine thegenerality of these conclusions regarding the stability of TM2
and TM3.
4.2. Effect of aspartic acid protonation state on TM2–3
secondary structure
Protonation of the aspartic acid residues of TM2–3 results in
a small but significant increase in the helical content of the
protein. The structural properties of other isolated transmem-
brane segments containing Asp residues are also known to
depend on protonation state. For example, due to the presence
of two Asp residues, a peptide corresponding to the ‘C’ helix of
bacteriorhodpsin adopts a helical structure and a transmembrane
configuration only at low pH [57]. Similarly, a significant
amount of a Leu-rich model transmembrane segment containing
an Asp residue resided in an interfacial location at neutral pH,
but protonation allowed a significant amount of the peptide to
adopt a transmembrane configuration, in which the Asp residue
is membrane-embedded [48].
In analogy with the results of the above two studies, a
reasonable explanation for the increase in the helical content of
TM2–3 at low pH is that at neutral pH, TM2 and TM3 are not
fully transmicellar, but reside at a shallower location in the
micelle where the charged Asp residues can interact with water
and/or the polar head groups of the detergent. Upon lowering
the pH, the Asp residues become protonated and the two TM
segments insert more deeply into the micelle, where their helical
structure is stabilized. To determine the effects of the proto-
nation of the individual Asp residues in TM2–3, site-directed
mutagenesis could be used to replace each Asp with Asn or Ala,
which would presumably mimic the effects of protonation.
4.3. Effect of detergent structure on TM2–3 secondary
structure
The fact that helix–helix interactions can stabilize the
structure of individual helices suggests that in the case of
TM2–3, differences in helicity in different detergents may be a
result of differences in the extent of tertiary interactions between
TM2 and TM3. However, the helicity of TM2–3 was found to
be highly similar in SDS and LDAO. SDS is a strongly
denaturing detergent, and would be expected to be much more
disruptive of helix–helix interactions than LDAO. This would
lead to significant differences in helicity between SDS and
LDAO. This was not observed, however, making it unlikely that
differences in helix–helix interactions are responsible for the
differences in helicity. Nevertheless, our data cannot rule out the
possibility that the observed detergent effect on TM2–TM3
helicity may result, in part, from an effect on TM2–TM3 inter-
actions. This issue could be more fully resolved by investigating
TM2–TM3 interactions using more rigorous techniques,
such as fluorescence resonance energy transfer or analytical
ultracentrifugation.
The data with different detergents presented in this work
suggest that a key detergent property affecting the helicity of
TM2–3 is the alkyl chain length. In the context of a detergent
micelle, a change in alkyl chain length will change the diameter
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micelle size. This could lead to a change in the extent of
hydrophobic mismatch between the micelle and hydrophobic,
micelle-spanning helices. The effects of hydrophobic mismatch
on the behaviour of model transmembrane helices in lipid
bilayers have been studied [58,59]. When the length of the helix
is well matched to the thickness of the bilayer, a transbilayer α
helical conformation predominates. Increases in the amount of
mismatch lead to an increase in the amount of peptide adopting
an interfacial location, presumably parallel to the bilayer plane
[58,59]. As described above for the effect of pH on TM2–3
structure, movement of a transmicellar helix to a more
peripheral location could, depending on the particular sequence
properties of the helix, lead to a reduction in the stability of the
helix, leading in turn to a reduction in the helical content of the
polypeptide. This could explain the difference in secondary
structure of TM2–3 in myristoyl-LPC and the three detergents
with shorter alkyl chain length (lauroyl-LPC, SDS and LDAO).
If this alkyl-chain-length effect is in fact a reflection of
hydrophobic matching between micelle and peptide, then one
might expect an optimal chain length for a given peptide/
protein, and chain lengths above or below this optimum would
give reduced stability/helicity. This hypothesis could be tested
by conducting experiments with detergents with a wider range
of chain lengths (e.g. 10–18 carbons).
4.4. Implications for folding of opioid receptors and other
GPCRs
The overall stability of an integral membrane protein can be
decomposed into the stability of the individual helices and the
stability of helix–helix interactions [60,61]. The results
presented in this paper suggest that in detergent solutions, the
stability of the μ-opioid receptor may be compromised by the
reduced stability of TM2 and TM3, and possibly other helices.
The results suggest further that changing factors such as pH and
detergent chain length can enhance the stability of these helices.
Only a limited number of detergents were studied in this work; a
wider study could presumably find detergents that further
stabilize TM2 and TM3 in the context of the results presented
here, which suggest that alkyl chain lengths of 14 carbons or
greater may be more likely to improve stability than shorter
chain detergents. Detergents that improve the stability of
transmembrane helices could be used for long-term storage of
integral membrane proteins, as well as during refolding
protocols, where fully formed transmembrane helices may be
important folding intermediates. Such detergents could also
allow long experiments such as NMR spectroscopy and
crystallization to be carried out with greater ease, as a result of
improved stability.
The Asp residue in TM2, as well as the ‘DRY’motif near the
end of TM3, is highly conserved in opioid receptors in
particular and rhodopsin-like GPCRs in general [1,3]. This
makes the result obtained here on the effect of pH on secondary
structure important, as it might likely apply to the other opioid
receptors and to other GPCRs. This information could facilitate
the development of refolding protocols for such proteins if theyare overexpressed in insoluble form, as in the case of the
μ-opioid receptor overexpressed in Pichia pastoris [22].
The knowledge that detergent structure and pH can have
subtle effects on transmembrane helix stability is also important
for studies on transmembrane helix–helix interactions. In
studies in which the effect of detergent structure on helix–
helix association is assessed, it is generally assumed that changes
in detergent structure do not affect helicity. This has been
demonstrated in some cases [45,62]. However, in those cases,
constant helicity was verified using detergents of identical chain
length, or under conditions where helix–helix interactions were
likely very significant. For future studies on interactions be-
tween transmembrane helices, the results presented in this
work suggest that the effect of detergent structure and pH on
helical stability should be taken into account, if accurate infor-
mation on the factors governing helix–helix association is to be
obtained.Acknowledgment
This work was supported by a grant from the Canadian
Institutes of Health Research.
References
[1] B.L. Kieffer, Recent advances in molecular recognition and signal
transduction of active peptides: receptors for opioid peptides, Cell. Mol.
Neurobiol. 15 (1995) 615–635.
[2] B.L. Kieffer, C. Gaveriaux-Ruff, Exploring the opioid system by gene
knockout, Prog. Neurobiol. 66 (2002) 285–306.
[3] T. Schoneberg, G. Schultz, T. Gudermann, Structural basis of G protein-
coupled receptor function, Mol. Cell. Endocrinol. 151 (1999) 181–193.
[4] P.Y. Law, Y.H. Wong, H.H. Loh, Mutational analysis of the structure and
function of opioid receptors, Biopolymers 51 (1999) 440–455.
[5] I.D. Pogozheva, M.J. Przydzial, H.I. Mosberg, Homology modeling of
opioid receptor–ligand complexes using experimental constraints, AAPS
J. 7 (2005) E434–E448.
[6] B.S. Zhorov, V.S. Ananthanarayanan, Homology models of mu-opioid
receptor with organic and inorganic cations at conserved aspartates in the
second and third transmembrane domains, Arch. Biochem. Biophys. 375
(2000) 31–49.
[7] C.B. Fowler, I.D. Pogozheva, H. LeVine III, H.I. Mosberg, Refinement of
a homology model of the mu-opioid receptor using distance constraints
from intrinsic and engineered zinc-binding sites, Biochemistry 43 (2004)
8700–8710.
[8] C.B. Fowler, I.D. Pogozheva, A.L. Lomize, H. LeVine III, H.I.
Mosberg, Complex of an active mu-opioid receptor with a cyclic pep-
tide agonist modeled from experimental constraints, Biochemistry 43
(2004) 15796–15810.
[9] R. Grisshammer, C.G. Tate, Overexpression of integral membrane proteins
for structural studies, Q. Rev. Biophys. 28 (1995) 315–422.
[10] A.D. Albert, P.L. Yeagle, Structural studies on rhodopsin, Biochim.
Biophys. Acta 1565 (2002) 183–195.
[11] K. Palczewski, T. Kumasaka, T. Hori, K.A. Behnke, H. Motoshima, B.A.
Fox, I. Le Trong, D.C. Teller, T. Okada, R.E. Stenkamp, M. Yamamoto,
M. Miyano, Crystal structure of rhodopsin: a G protein-coupled receptor,
Science 289 (2000) 739–745.
[12] B.K. Kobilka, Agonist-induced conformational changes in the beta2
adrenergic receptor, J. Pept. Res. 60 (2002) 317–321.
[13] B. Kobilka, U. Gether, R. Seifert, S. Lin, P. Ghanouni, Examination of
ligand-induced conformational changes in the beta2 adrenergic receptor,
Life Sci. 62 (1998) 1509–1512.
1209A. Kerman, V.S. Ananthanarayanan / Biochimica et Biophysica Acta 1768 (2007) 1199–1210[14] H. Kiefer, J. Krieger, J.D. Olszewski, G. Von Heijne, G.D. Prestwich, H.
Breer, Expression of an olfactory receptor in Escherichia coli: purification,
reconstitution, and ligand binding, Biochemistry 35 (1996) 16077–16084.
[15] J.L. Baneres, A. Martin, P. Hullot, J.P. Girard, J.C. Rossi, J. Parello,
Structure-based analysis of GPCR function: conformational adaptation of
both agonist and receptor upon leukotriene B4 binding to recombinant
BLT1, J. Mol. Biol. 329 (2003) 801–814.
[16] J.L. Baneres, J. Parello, Structure-based analysis of GPCR function:
evidence for a novel pentameric assembly between the dimeric leukotriene
B4 receptor BLT1 and the G-protein, J. Mol. Biol. 329 (2003) 815–829.
[17] C. Tian, R.M. Breyer, H.J. Kim, M.D. Karra, D.B. Friedman, A. Karpay,
C.R. Sanders, Solution NMR spectroscopy of the human vasopressin V2
receptor, a G protein-coupled receptor, J. Am. Chem. Soc. 127 (2005)
8010–8011.
[18] J.L. Baneres, D. Mesnier, A. Martin, L. Joubert, A. Dumuis, J. Bockaert,
Molecular characterization of a purified 5-HT4 receptor: a structural basis
for drug efficacy, J. Biol. Chem. 280 (2005) 20253–20260.
[19] S.H. Park, S. Prytulla, A.A. De Angelis, J.M. Brown, H. Kiefer, S.J.
Opella, High-resolution NMR spectroscopy of a GPCR in aligned bicelles,
J. Am. Chem. Soc. 128 (2006) 7402–7403.
[20] I.D. Alves, K.A. Ciano, V. Boguslavski, E. Varga, Z. Salamon, H.I.
Yamamura, V.J. Hruby, G. Tollin, Selectivity, cooperativity, and reci-
procity in the interactions between the delta-opioid receptor, its ligands,
and G-proteins, J. Biol. Chem. 279 (2004) 44673–44682.
[21] Z. Salamon, S. Cowell, E. Varga, H.I. Yamamura, V.J. Hruby, G. Tollin,
Plasmon resonance studies of agonist/antagonist binding to the human
delta-opioid receptor: new structural insights into receptor–ligand
interactions, Biophys. J. 79 (2000) 2463–2474.
[22] V. Sarramegna, I. Muller, G. Mousseau, C. Froment, B. Monsarrat, A.
Milon, F. Talmont, Solubilization, purification and mass spectrometry
analysis of the human mu-opioid receptor expressed in Pichia pastoris,
Protein Expr. Purif. 43 (2005) 85–93.
[23] J.F. Hunt, T.N. Earnest, O. Bousche, K. Kalghatgi, K. Reilly, C. Horvath,
K.J. Rothschild, D.M. Engelman, A biophysical study of integral
membrane protein folding, Biochemistry 36 (1997) 15156–15176.
[24] P.L. Yeagle, G. Choi, A.D. Albert, Studies on the structure of the G-
protein-coupled receptor rhodopsin including the putative G-protein
binding site in unactivated and activated forms, Biochemistry 40 (2001)
11932–11937.
[25] D. Thevenin, M.F. Roberts, T. Lazarova, C.R. Robinson, Identifying
interactions between transmembrane helices from the adenosine A2A
receptor, Biochemistry 44 (2005) 16239–16245.
[26] E. Arevalo, R. Estephan, J. Madeo, B. Arshava, M. Dumont, J.M. Becker,
F. Naider, Biosynthesis and biophysical analysis of domains of a yeast G
protein-coupled receptor, Biopolymers 71 (2003) 516–531.
[27] R. Estephan, J. Englander, B. Arshava, K.L. Samples, J.M. Becker, F.
Naider, Biosynthesis and NMR analysis of a 73-residue domain of a
Saccharomyces cerevisiae G protein-coupled receptor, Biochemistry 44
(2005) 11795–11810.
[28] I. Fadhil, R. Schmidt, C. Walpole, K.A. Carpenter, Exploring deltorphin II
binding to the third extracellular loop of the delta-opioid receptor, J. Biol.
Chem. 279 (2004) 21069–21077.
[29] L. Zhang, R.N. DeHaven, M. Goodman, NMR and modeling studies of a
synthetic extracellular loop II of the kappa opioid receptor in a DPC
micelle, Biochemistry 41 (2002) 61–68.
[30] T.W. Kahn, D.M. Engelman, Bacteriorhodopsin can be refolded from two
independently stable transmembrane helices and the complementary five-
helix fragment, Biochemistry 31 (1992) 6144–6151.
[31] A. Kerman, V.S. Ananthanarayanan, Expression and spectroscopic
characterization of a large fragment of the μ-opioid receptor, Biochim.
Biophys. Acta 1747 (2005) 133–140.
[32] J. Sambrook, E.F. Fritxch, T. Maniatis, Molecular Cloning: A Laboratory
Manual, Cold Spring Harbor Press, Plainview, NY, 1989 (Chapter 1).
[33] C.N. Pace, F. Vajdos, L. Fee, G. Grimsley, T. Gray, How to measure and
predict the molar absorption coefficient of a protein, Protein Sci. 4 (1995)
2411–2423.
[34] S.W. Provencher, J. Glockner, Estimation of globular protein secondary
structure from circular dichroism, Biochemistry 20 (1981) 33–37.[35] W.C. Johnson Jr., Analyzing protein circular dichroism spectra for accurate
secondary structures, Proteins: Struct., Funct., Genet. 35 (1999) 307–312.
[36] N. Sreerama, R.W. Woody, A self-consistent method for the analysis of
protein secondary structure from circular dichroism, Anal. Biochem. 209
(1993) 32–44.
[37] N. Sreerama, R.W. Woody, Estimation of protein secondary structure from
circular dichroism spectra: comparison of CONTIN, SELCON, and
CDSSTR methods with an expanded reference set, Anal. Biochem. 287
(2000) 252–260.
[38] H. Schagger, G. von Jagow, Tricine-sodium dodecyl sulfate-polyacryla-
mide gel electrophoresis for the separation of proteins in the range from 1
to 100 kDa, Anal. Biochem. 166 (1987) 368–379.
[39] M. Ramjeesingh, L.J. Huan, E. Garami, C.E. Bear, Novel method for
evaluation of the oligomeric structure of membrane proteins, Biochem. J.
342 (1999) 119–123.
[40] A. Mestek, J.H. Hurley, L.S. Bye, A.D. Campbell, Y. Chen, M. Tian, J.
Liu, H. Schulman, L. Yu, The human mu opioid receptor: modulation of
functional desensitization by calcium/calmodulin-dependent protein
kinase and protein kinase C, J. Neurosci. 15 (1995) 2396–2406.
[41] A.G. Therien, M. Glibowicka, C.M. Deber, Expression and purification of
two hydrophobic double-spanning membrane proteins derived from the
cystic fibrosis transmembrane conductance regulator, Protein Expr. Purif.
25 (2002) 81–86.
[42] R.M. Johnson, C.L. Heslop, C.M. Deber, Hydrophobic helical hairpins:
design and packing interactions in membrane environments, Biochemistry
43 (2004) 14361–14369.
[43] N. Sreerama, R.W. Woody, On the analysis of membrane protein circular
dichroism spectra, Protein Sci. 13 (2004) 100–112.
[44] K. Shiraki, K. Nishikawa, Y. Goto, Trifluoroethanol-induced stabilization
of the alpha-helical structure of beta-lactoglobulin: implication for non-
hierarchical protein folding, J. Mol. Biol. 245 (1995) 180–194.
[45] A.G. Therien, C.M. Deber, Interhelical packing in detergent micelles.
Folding of a cystic fibrosis transmembrane conductance regulator
construct, J. Biol. Chem. 277 (2002) 6067–6072.
[46] A. Fontana, P.P. de Laureto, B. Spolaore, E. Frare, P. Picotti, M. Zambonin,
Probing protein structure by limited proteolysis, Acta Biochim. Pol. 51
(2004) 299–321.
[47] S.J. Hubbard, The structural aspects of limited proteolysis of native
proteins, Biochim. Biophys. Acta 1382 (1998) 191–206.
[48] G.A. Caputo, E. London, Position and ionization state of Asp in the core of
membrane-inserted alpha helices control both the equilibrium between
transmembrane and nontransmembrane helix topography and transmem-
brane helix positioning, Biochemistry 43 (2004) 8794–8806.
[49] A.T. Alexandrescu, Y.L. Ng, C.M. Dobson, Characterization of a
trifluoroethanol-induced partially folded state of alpha-lactalbumin, J.
Mol. Biol. 235 (1994) 587–599.
[50] Y. Kuroda, D. Hamada, T. Tanaka, Y. Goto, High helicity of peptide
fragments corresponding to beta-strand regions of beta-lactoglobulin
observed by 2D-NMR spectroscopy, Fold. Des. 1 (1996) 255–263.
[51] M.W. Maciejewski, M.H. Zehfus, Structure of a compact peptide from
staphylococcal nuclease determined by circular dichroism and NMR
spectroscopy, Biochemistry 34 (1995) 5795–5800.
[52] F.J. Blanco, M.A. Jimenez, A. Pineda, M. Rico, J. Santoro, J.L. Nieto,
NMR solution structure of the isolated N-terminal fragment of protein-G
B1 domain. Evidence of trifluoroethanol induced native-like beta-hairpin
formation, Biochemistry 33 (1994) 6004–6014.
[53] C.M. Santiveri, D. Pantoja-Uceda, M. Rico, M.A. Jimenez, Beta-hairpin
formation in aqueous solution and in the presence of trifluoroethanol: a (1)
H and (13)C nuclear magnetic resonance conformational study of designed
peptides, Biopolymers 79 (2005) 150–162.
[54] F.X. Ding, H. Xie, B. Arshava, J.M. Becker, F. Naider, ATR-FTIR study of
the structure and orientation of transmembrane domains of the Saccharo-
myces cerevisiae alpha-mating factor receptor in phospholipids, Biochem-
istry 40 (2001) 8945–8954.
[55] J. Luneberg, M. Widmann, M. Dathe, T. Marti, Secondary structure of
bacteriorhodopsin fragments. External sequence constraints specify the
conformation of transmembrane helices, J. Biol. Chem. 273 (1998)
28822–28830.
1210 A. Kerman, V.S. Ananthanarayanan / Biochimica et Biophysica Acta 1768 (2007) 1199–1210[56] D.M. Engelman, T.A. Steitz, The spontaneous insertion of proteins into
and across membranes: the helical hairpin hypothesis, Cell 23 (1981)
411–422.
[57] J.F. Hunt, P. Rath, K.J. Rothschild, D.M. Engelman, Spontaneous, pH-
dependent membrane insertion of a transbilayer alpha-helix, Biochemistry
36 (1997) 15177–15192.
[58] G.A. Caputo, E. London, Cumulative effects of amino acid substitutions and
hydrophobic mismatch upon the transmembrane stability and conformation
of hydrophobic alpha-helices, Biochemistry 42 (2003) 3275–3285.
[59] M.R. de Planque, J.A. Killian, Protein-lipid interactions studied withdesigned transmembrane peptides: role of hydrophobic matching and
interfacial anchoring, Mol. Membr. Biol. 20 (2003) 271–284.
[60] S.H. White, W.C. Wimley, Membrane protein folding and stability:
physical principles, Annu. Rev. Biophys. Biomol. Struct. 28 (1999)
319–365.
[61] J.L. Popot, D.M. Engelman, Membrane protein folding and oligomeriza-
tion: the two-stage model, Biochemistry 29 (1990) 4031–4037.
[62] L.E. Fisher, D.M. Engelman, J.N. Sturgis, Detergents modulate dimeriza-
tion, but not helicity, of the glycophorin A transmembrane domain, J. Mol.
Biol. 293 (1999) 639–651.
